Sereda
Algirdas-Vladimir I. Sereda, Murmansk RU
Patent application number | Description | Published |
---|---|---|
20090119076 | Method for Generating a 3D Earth Model - A method is provided for generating an invertible 3D hydrodynamic earth model suitable for defining target characteristics of a subsurface area formed by a plurality of formations and comprising drilling positions of potential and real wells. The method comprises constructing an initial 3D earth model by combining solutions for a set of single 1D models, each of the models corresponding to a real or potential well drilling position and covering the entire respective aggregate of formations along the wellbore, with solutions for a relevant set of 2D earth models which are constructed only for single formations, and optimizing the constructed initial 3D earth model by defining an optimal set of formations and an optimal set of calibratable model parameters. A method and system are also provided for application of the earth model construction method for predicting overpressure evolution before and during drilling. As the earth model constructed in accordance with the above method provides efficient inversion of data, in particular gathered while drilling, the prediction can be updated in real-time while drilling. The invention can ensure optimization of the drilling process and improves its safety. | 05-07-2009 |
Grigoriy Sereda, Vermillion, SD US
Patent application number | Description | Published |
---|---|---|
20140287438 | Rapid and Inexpensive Assay for Evaluation of Antibody Efficacy with Custom-Designed Fluorescent Nanoparticles - A method for determining the efficacy of a vaccine comprising: providing serum from an animal inoculated with a vaccine; providing a plurality of antigen-linked nanoparticles; contacting the serum with the plurality of antigen linked nanoparticles; contacting the serum and the plurality of antigen linked nanoparticles with a plurality of Fc receptor-expressing cells; measuring amount antigen-linked nanoparticle uptake by of the Fc receptor-expressing cells; determining efficacy of the vaccine by comparing the level of antigen-linked nanoparticle uptake to a baseline level of uptake wherein a greater nanoparticle uptake compared to the baseline level of uptake is indicative of greater vaccine efficacy. | 09-25-2014 |
Konstantin Sereda, Kharkiv UA
Patent application number | Description | Published |
---|---|---|
20090020415 | "Iontron" ion beam deposition source and a method for sputter deposition of different layers using this source - The present invention discloses technology for thin film ion beam sputter deposition on a substrate. The apparatus is a self-contained ion beam deposition source, which can be attached to or positioned inside of a vacuum chamber where substrates are located. This source consists of one or more ion beam sources combined with one or more sputtering targets and a unified magnetic field acting as a devise controlling delivery of the charged particles to the treated by the Iontron workpiece (substrate). The ion beam emits ion beams toward the target that generate sputtered particles directed toward the substrate, thus creating a thin film on the surface of the substrate. The target can be electrically biased, not biased or floating, thus allowing for modulation of the location upon which the charged ions impinge the target. Additionally, the position of the target can be adjusted relatively to the ion beam. | 01-22-2009 |
Luciane Sereda, Campinas BR
Patent application number | Description | Published |
---|---|---|
20140018468 | FOUNDRY BINDER SYSTEMS - The present invention relates to foundry binder systems forming a curable polyurethane with a catalytically effective amount of a curing catalyst, comprising at least one phenolic resin component comprising at least: a phenolic resin and a solvent of triacetin type and a polyisocyanate component. The invention also relates to foundry mixtures prepared from the binder and an aggregate, to foundry forms such as cores and molds prepared via the no-bake or cold-box processes, and also to the respective processes. The foundry forms obtained by the present invention are especially used for manufacturing metallic components, especially for the casting of metallic components. | 01-16-2014 |
Terrance Jimmy Sereda, Winnipeg CA
Patent application number | Description | Published |
---|---|---|
20090029911 | Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol - A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, polyethylene glycol, a tonicifier such as a sugar alcohol, and optionally, an antimicrobial agent and optionally, a chelating agent. Also disclosed are associated means and methods for preparing, storing and using such formulations. | 01-29-2009 |